Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Elicio Therapeutics, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
Prev close 1.99 · gapped below the open, then crossed back over prior close. High/low 2.02 at 4:30 pm ET, 1.94 at 9:45 am ET.
ELTX (Elicio Therapeutics, Inc.) has 10 disclosed suppliers and 1 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
54 institutional managers report a position in Elicio Therapeutics, Inc. worth $22.6M between them, filed on form 13F for the quarter ending 2026-06-30. 11 of them hold 80% of it, the largest being Knoll Capital Management, LP at 20.94%.
29 more managers in the register
11 managers hold 80% of the $22.6M institutional base. The other 43 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 78 days old and does not move with the price above it.
via Knoll Capital Management, LP · 20.94% of ELTX, 55.17% of ENTX
via Knoll Capital Management, LP, Caption Management, LLC · 20.94% of ELTX, 14.72% of ALDX
via Ikarian Capital, LLC, Diadema Partners LP, Boothbay Fund Management, LLC · 5.43% of ELTX, 6.19% of CUE
via Ikarian Capital, LLC, Diadema Partners LP, Boothbay Fund Management, LLC · 5.43% of ELTX, 19.39% of PTHS
via Ikarian Capital, LLC, Boothbay Fund Management, LLC, Diadema Partners LP · 5.43% of ELTX, 5.64% of PRQR
via Ikarian Capital, LLC, Boothbay Fund Management, LLC, Diadema Partners LP · 5.43% of ELTX, 32.67% of CNTB
Managers holding a meaningful stake in ELTX also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.